medscape
Ovarian cancer continues to be the most lethal gynecologic
malignancy. Currently, screening for this disease in average-risk women
is not recommended owing to a high rate of false-positive test results
that lead to unnecessary surgery.[1]
In an April 2009 commentary, I summarized initial findings from a British trial[2]
of ovarian cancer screening in more than 200,000 postmenopausal women.
Six years later, these UK investigators have reported their preliminary
findings with respect to impact on mortality.[3]......Although the road forward continues to be challenging, this trial's
findings bring us one step closer to routine screening for ovarian
cancer.
An ovarian cancer blog which includes quality resource materials: education, research, social networking, genetics and (some) healthcare politics.
“Not everything that can be counted counts and not everything that counts can be counted.”
Albert Einstein
No comments:
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.